ANTITUMORMITTEL

European patent · EP4129304 · In force

Register entry

Publication number
EP4129304
Application number
EP21781882
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 2, 2021
Published
Feb 8, 2023
Granted
Sep 18, 2024
Protection ends at the latest
Apr 1, 2041
Next annual fee due
Apr 30, 2027
IPC classes
A61K 9/127 (2006.01)
A61K 31/7068 (2006.01)
A61P 35/00 (2006.01)
A61K 9/10 (2006.01)
Priority
US 202063004733 P 03.04.2020
JP 2020086495 18.05.2020
PCT application
PCT/JP2021/014285 02.04.2021
PCT publication
WO2021/201267 07.10.2021
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. Jul 30, 2025

    Change

    Published in Swissreg on 30.07.2025

  3. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  4. Sep 26, 2024

    Agent entered

    Representative
    Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg

    Published in Swissreg on 26.09.2024

  5. Sep 18, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 18.09.2024

Parties

Holder

FUJIFILM Corporation

26-30, Nishiazabu 2-chome Minato-ku, Tokyo 106-8620, JP

Agent

Servopatent GmbH

Bühlstrasse 1, 8125 Zollikerberg

Inventor

MATSUMOTO Takeshi

Ashigarakami-gun, Kanagawa 258-8577, JP

KAKINUMA Chihaya

Ashigarakami-gun, Kanagawa 258-8577, JP

MAKITA Keiko

Ashigarakami-gun, Kanagawa 258-8577, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.